Page last updated: 2024-10-21

3,4-methylenedioxyamphetamine and Benign Neoplasms, Brain

3,4-methylenedioxyamphetamine has been researched along with Benign Neoplasms, Brain in 1 studies

3,4-Methylenedioxyamphetamine: An amphetamine derivative that inhibits uptake of catecholamine neurotransmitters. It is a hallucinogen. It is less toxic than its methylated derivative but in sufficient doses may still destroy serotonergic neurons and has been used for that purpose experimentally.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Kaye, EC1
Kegel, A1
Weber, M1
Cartwright, C1
Spraker-Perlman, H1
Robinson, GW1
Baker, JN1

Other Studies

1 other study available for 3,4-methylenedioxyamphetamine and Benign Neoplasms, Brain

ArticleYear
Food Is Love: Partnering With Families to Provide Nourishment at the End of Life.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2020, 06-01, Volume: 38, Issue:16

    Topics: Administration, Cutaneous; Brain Neoplasms; Death; Fluid Therapy; Grief; Humans; Love; Massage; Moth

2020